API

PO API Capsule | API Pharmaceutical Outsourcing

An active pharmaceutical ingredient (API) is defined in ICH Q7 as “any substance or mixture of substances intended to be used in the manufacture of a drug product and that, when used in the production of a drug, becomes an active ingredient in the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the body.”

Active pharmaceutical ingredients are distinguishable from inactive pharmaceutical ingredients, commonly known as excipients or formulation aids.

The European Medicines Agency, and the US FDA have adopted the ICH Q7 definition of APIs.

Many other terms are used interchangeably with API. They include:

  • active
  • bulk pharmaceutical chemical
  • drug substance
  • active principle (especially for natural extracts)
  • therapeutic ingredient

Filter

Hide Filter
  • Celonic Group Signs Manufacturing Service Agreement with LINDIS Biotech

    Wednesday, February 19, 2025
    Celonic Group announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech for the production of catumaxomab for commercial supply. read more
  • Celerion Expands UK Phase 1 Clinical Research Operations

    Wednesday, February 19, 2025
    Celerion announced a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health. This state-of-the-art clinical research center, led by Queen’s University Belfast, in partnership with the Belfast Health and Social Care ... read more
  • American Injectables Announces Key Leadership Appointments

    Tuesday, February 18, 2025
    American Injectables announced strategic leadership appointments to position the company for continued growth in 2025 and beyond. These changes come at a crucial time in the pharmaceutical manufacturing industry, as demand for domestic production ... read more
  • Upperton Completes Sterile Manufacturing Facility

    Wednesday, January 29, 2025
    Upperton Pharma Solutions has completed the build of its new sterile manufacturing facility in Nottingham, UK. read more
  • Kenox Pharmaceuticals Expands Capabilities

    Wednesday, January 29, 2025
    Kenox Pharmaceuticals Inc. announced the addition of small scale non-sterile GMP capabilities to support GLP pre-clinical studies to its comprehensive suite of drug development services. read more
  • Polyrizon Starts GMP Manufacturing Preliminary Process With Eurofins

    Thursday, January 23, 2025
    Polyrizon Ltd. has commenced preliminary work related to the Good Manufacturing Practice (GMP) manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical trial. The company works closely with Eurofins CDMO, ... read more
  • SGS Launches Cell Sorting Service

    Thursday, January 23, 2025
    SGS announced the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry. read more
  • Catalent to Collaborate with Galapagos

    Wednesday, January 22, 2025
    Catalent, Inc. announced a strategic collaboration with Galapagos NV to support decentralized manufacturing for clinical studies of GLPG5101, Galapagos’ investigational CAR-T therapy for relapsed/refractory non-Hodgkin lymphoma (NHL) indications. read more
  • PharmAla to Supply Merhavim Mental Health Centre Clinical Trial

    Tuesday, January 21, 2025
    PharmAla Biotech Holdings Inc. has executed an agreement with Merhavim Mental Health Centre of Beer Yaakov, Israel. read more
  • Kindeva Drug Delivery Awarded Contract to Supply Autoinjectors

    Tuesday, January 21, 2025
    Kindeva Drug Delivery's global health security division, Meridian Medical Technologies, LLC, secured a contract valued at up to $129 million to supply DuoDote®, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS), ... read more
  • Pharmaceutical Manufacturing Program Launched

    Tuesday, January 21, 2025
    In response to the growing demand for skilled professionals in South Carolina's life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in the summer of ... read more
  • Optimizing Cell and Gene Therapy Workflows

    Thursday, January 16, 2025
    Cell and gene therapies are at the forefront of efforts toward transformative medicine where diseases can be treated by the restoration or reconditioning of cells or genes. Crucial to their development is the large-scale cultivation and production of... read more
  • Alcami Names New CEO

    Tuesday, January 14, 2025
    Alcami Corporation announced the resignation of Bill Humphries. Alcami’s Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from ... read more
  • Avéma Pharma Solutions Moved Under PLD Banner

    Tuesday, January 14, 2025
    With this move, PLD is consolidating its divisions with a unified identity that reflects the company’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers. read more
  • dbDNA™ Manufacturing Facility Receives GMP License from MHRA

    Tuesday, January 14, 2025
    Touchlight has received a Manufacturer’s Authorization for Investigational Medicinal Products (MIA, IMP) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the GMP (Good Manufacturing Practices) production of ... read more